About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Vcltm1Eda
targeted mutation 1, Eileen D Adamson
MGI:1857730
Summary 2 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Vcltm1Eda/Vcltm1Eda involves: 129S1/Sv * 129X1/SvJ * Black Swiss MGI:2174798
ht2
Vcltm1Eda/Vcl+ involves: 129S1/Sv * 129X1/SvJ * Black Swiss MGI:3613011


Genotype
MGI:2174798
hm1
Allelic
Composition
Vcltm1Eda/Vcltm1Eda
Genetic
Background
involves: 129S1/Sv * 129X1/SvJ * Black Swiss
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Vcltm1Eda mutation (0 available); any Vcl mutation (48 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• homozygous mutant embryos die between E8.5 and E10.5
• only 16% of mutant embryos survive until E10.5, with fatal degeneration evident at E9.5

nervous system
• by E9.5, the cells of the neuroepithelium are disarrayed and the neuroepithelium layer is distorted, with many cells degenerating
• at E8.5, homozygotes display a thinner neuroepithelium layer
• at E9.5, mutant cephalic neural folds fail to fuse resulting in an open diocoel; the myelocoel appears small and/or distorted
• by E10.5, all homozygotes show absence of midline fusion of the rostral neural tube, resulting in a cranial bilobular appearance
• at E9.5, homozygotes exhibit a significantly reduced brain
• at E9.5, mutant brain ventricles are absent or small
• at E9.5, mutant brain ventricles are absent or small
• at E10.5, homozygotes show paucity of cranial nerve development
• at E10.5, mutant dorsal root ganglia and nerve tracks appear thin and barely detectable
• at E10.5, homozygotes show paucity of spinal nerve development

cardiovascular system
• at E9.5, homozygotes exhibit a severe reduction in cardiomyocytes
• at E9.5, homozygotes display thin walls with only a few cardiomyocytes present
• at E9.5, homozygotes display abnormal or significantly delayed cardiac development, resulting in small cardiac structures at E10.5
• at E9.5, the endocardium is present but cushions fail to form
• at E9.5, mutant hearts are oriented in a downward slant rather than perpendicular to the spinal cord
• at E9.5, mutant hearts are approximately 50% of wild-type size
• at E9.5, homozygotes show absence of cardiac valve formation
• at E10.5, homozygotes display a significantly dilated pericardial cavity
• at E9.5, mutant hearts fail to contract; however, upon transfer to tissue culture, mutant cardiomyocytes are shown to contract rhythmically

embryo
• at E9.5, homozygotes show absence of the head ectoderm
• at E8.5, homozygotes exhibit mesoderm in both embryonic and extraembryonic tissues; however, mutant mesodermal cells are reduced in number and appear more condensed
• at E8.5, homozygotes display a reduced anterior-posterior axis relative to wild-type embryos
• homozygous mutant embryos fail to develop beyond E10
• at E9.5, mutant embryos are structurally fragile and do not survive fixation and embedding as well as wild-type embryos
• at E8.5, homozygotes show significant developmental retardation relative to wild-type embryos
• at E9.5-E10, homozygotes are 30%-40% smaller than wild-type embryos
• at E10.5, homozygotes display asymmetrically positioned forelimb buds
• at E10.5, homozygotes display small forelimb buds
• at E8.5, mutant neural folds appear thin and distorted within a malformed neural groove
• by E9.5, the cells of the neuroepithelium are disarrayed and the neuroepithelium layer is distorted, with many cells degenerating
• at E8.5, homozygotes display a thinner neuroepithelium layer
• at E9.5, mutant cephalic neural folds fail to fuse resulting in an open diocoel; the myelocoel appears small and/or distorted
• by E10.5, all homozygotes show absence of midline fusion of the rostral neural tube, resulting in a cranial bilobular appearance
• at E9.5, homozygotes display abnormally small somites
• at E9.5, homozygotes display reduced somite density

growth/size/body
• at E10.5, homozygotes fail to fuse the head structures in the ventral cranial midline and exhibit an abnormal head shape
• at E8.5, homozygotes show significant developmental retardation relative to wild-type embryos
• at E9.5-E10, homozygotes are 30%-40% smaller than wild-type embryos

craniofacial
• at E10.5, homozygotes fail to fuse the head structures in the ventral cranial midline and exhibit an abnormal head shape

muscle
• at E9.5, homozygotes exhibit a severe reduction in cardiomyocytes
• at E9.5, homozygotes display thin walls with only a few cardiomyocytes present
• at E9.5, mutant hearts fail to contract; however, upon transfer to tissue culture, mutant cardiomyocytes are shown to contract rhythmically

limbs/digits/tail
• at E10.5, homozygotes display asymmetrically positioned forelimb buds
• at E10.5, homozygotes display small forelimb buds

digestive/alimentary system
• at E8.5, homozygotes exhibit a vestigial foregut

cellular
• in cultute, MEFs isolated from E10.5 mutant embryos exhibit reduced adhesion to fibronectin, vitronectin, laminin and collagen compared to wild-type MEFs
• in cultute, MEFs isolated from E10.5 mutant embryos exhibit a 2-fold increase in the migration rates over fibronectin, vitronectin, laminin and collagen relative to wild-type MEFs
• in addition, the level of focal adhesion kinase (FAK) activity is 3-fold higher relative to the wild-type level




Genotype
MGI:3613011
ht2
Allelic
Composition
Vcltm1Eda/Vcl+
Genetic
Background
involves: 129S1/Sv * 129X1/SvJ * Black Swiss
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Vcltm1Eda mutation (0 available); any Vcl mutation (48 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• heterozygotes display increased mortality following acute hemodynamic stress induced by transverse aortic constriction (TAC), with 33% dying spontaneously during the first 3 to 6 hrs following initial postoperative recovery
• only 30% of heterozygotes survive up to the full 12-week period following TAC versus 100% of wild-type mice

cardiovascular system
• heterozygotes exhibit normal costamere distribution but disorganized and widened intercalated disks (ICDs) as well as altered ICD-related protein distribution
• at 4 months, unstressed heterozygotes show misalignment of alpha-actinin containing Z-lines and abnormal myocardial ultrastructure despite preserved cardiac function; myofibrils appear less densely packed and are interrupted occasionally by swollen and disorganized mitochondria
• in heterozygotes, changes in myofibrillar attachment to Z-lines and ICDs become even more pronounced after TAC-induced stress, whereas no alterations occur in stressed wild-type mice
• heterozygotes show no significant changes in baseline ventricular function as determined by invasive catheterization or echocardiography up to 18 months of age
• however, beginning at 6 weeks post-TAC, heterozygotes exhibit decreased left ventricular function associated with an increased end-systolic dimension
• heterozygotes develop normally and display normal basal cardiac function and histology but show abnormal baseline electrocardiograms relative to wild-type mice
• electrocardiograms indicate normal PR duration but significantly prolonged QRS complexes in heterozygotes relative to wild-type mice
• no significant differences are detected in heart rate, pressure, or hemodynamic responses at baseline or after adrenergic stimulation

muscle
• heterozygotes exhibit normal costamere distribution but disorganized and widened intercalated disks (ICDs) as well as altered ICD-related protein distribution
• at 4 months, unstressed heterozygotes show misalignment of alpha-actinin containing Z-lines and abnormal myocardial ultrastructure despite preserved cardiac function; myofibrils appear less densely packed and are interrupted occasionally by swollen and disorganized mitochondria
• in heterozygotes, changes in myofibrillar attachment to Z-lines and ICDs become even more pronounced after TAC-induced stress, whereas no alterations occur in stressed wild-type mice
• heterozygotes show no significant changes in baseline ventricular function as determined by invasive catheterization or echocardiography up to 18 months of age
• however, beginning at 6 weeks post-TAC, heterozygotes exhibit decreased left ventricular function associated with an increased end-systolic dimension





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
04/16/2024
MGI 6.23
The Jackson Laboratory